Insider Trading History of Mulligan Richard

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mulligan Richard since 2013. This trader's CIK number is 1376247. At the time of last reporting, Mulligan Richard was the Officer of Sana Biotechnology, Inc.. (stock ticker symbol SANA). Also see all insider trading activities at Sana Biotechnology, Inc..

Note that in the past Mulligan Richard also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Biogen Inc. (BIIB) by Mulligan Richard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 BIIB 0 $0 48,855 $11,019,727 40,975 $2,189,294

Yearly summary of insider trading at Sana Biotechnology, Inc. (SANA) by Mulligan Richard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 SANA 0 $0 300,000 $1,195,800 0 $0


Insider trading activities at 2 companies by Mulligan Richard:

1. Biogen Inc. (BIIB)

2. Sana Biotechnology, Inc. (SANA)

Table 1. Insider trading of Biogen Inc. (BIIB) by Mulligan Richard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-05-29 BIIB Option Ex 3,000 53.43 160,290
2013-05-28 BIIB Sale 37,975 239.85 9,108,265
2013-05-28 BIIB Option Ex 37,975 53.43 2,029,004
2013-03-22 BIIB Sale 2,900 176.88 512,952
2013-03-13 BIIB Sale 7,980 175.25 1,398,510

Table 2. Insider trading of Sana Biotechnology, Inc. (SANA) by Mulligan Richard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-09-24 SANA Sale 150,000 4.08 612,600
2024-09-25 SANA Sale 150,000 3.89 583,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mulligan Richard (Officer of Sana Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.